Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 21 Jan, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2025 to 31 Dec, 2025

Specific Details American Chamber of Commerce Event

Intended results Fast and Fair access to new treatments for Irish patients and importance of a published Life Science Strategy in advance of the EU Presidency.

Name of person primarily responsible for lobbying on this activity Eibhlin Mulroe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

Attended the Thanksgiving event organised by the American Chamber of Commerce on the 25th November, met the Taoiseach and mentioned the importance of the Life Science Strategy and fast and fair access. Also introduced the Taoiseach to Giulia Conti, our new Country President, and Stefan Hendriks member of our Region Europe leadership.

Email (1)

Email in advance of the event to seek an introduction.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Micheál Martin Taoiseach (Dáil Éireann, the Oireachtas)

Deirdre Gillane Chief of Staff (Department of the Taoiseach)